tiprankstipranks

Steve Aselage Insider Profile

4 Followers
Steve Aselage, Director at Travere Therapeutics, holds 72.66K shares in BioCryst (Ticker: BCRX), holds 0.00 shares in Acer Therapeutics (Ticker: ACER), holds 146.92K shares in Travere Therapeutics (Ticker: TVTX).
tipranks
Steve Aselage

Steve Aselage
Travere Therapeutics (TVTX)
Director

Ranked #9,620 out of 97,997 Corporate Insiders

Profitable Transactions

47%
7 out of 15 Profitable Transactions

Average Return

+13.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$7M
71.78%
20.72%
7.50%
A breakdown of Steve Aselage's holdings

Insider Roles

BioMarin Pharmaceutical
(BMRN)
EVP, Chief Business Officer
Travere Therapeutics
(TVTX)
Director
BioCryst
(BCRX)
Director
Roles that Steve Aselage holds in companies

Most Profitable Insider Trade

Stock:
BioCryst
(BCRX)
Rating:Informative Buy
Date:Nov 18, 2019 - Nov 18, 2020
Return:+151.70%
The most profitable trade made by Steve Aselage

Steve Aselage's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Travere Therapeutics
May 12, 2022
Director
Uninformative Sell
56.44K
$1.44M
ACER
Acer Therapeutics
Nov 20, 2023
Uninformative Sell
$0.00
BioCryst
Jun 14, 2024
Director
Uninformative Buy
$521.69K
BioMarin Pharmaceutical
Jul 05, 2012
EVP, Chief Business Officer
Uninformative Sell
3.81M
$4.99M
CTIC
CTI BioPharma
List of latest transactions for each holding click on a transaction to see Steve Aselage's performance on stock

Steve Aselage insider profile FAQ

What is the percentage of profitable transactions made by Steve Aselage?
The percentage of profitable transactions made by Steve Aselage is 47%.
    What is the average return per transaction made by Steve Aselage?
    The average return per transaction made by Steve Aselage is 13.50%.
      What stocks does Steve Aselage hold?
      Steve Aselage holds: TVTX, ACER, BCRX, BMRN, CTIC stocks.
        What was Steve Aselage’s latest transaction?
        Steve Aselage latest transaction was an Uninformative Buy of ―.
          What was Steve Aselage's most profitable transaction?
          Steve Aselage’s most profitable transaction was an Informative Buy of BCRX stock on November 18, 2019. The return on the trade was 151.70%.
            What is Steve Aselage's role in Travere Therapeutics?
            Steve Aselage's role in Travere Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.